Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZISAST: Azithromycin as Add-on Therapy in Severe, Non-Eosinophilic Asthma
2008-004089-15Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma and non-eosinophilic asthma (NEA) comparing Azithromycin add-on with Placebo add-on (2 arms). Primary endpoint: Rate of severe asthma exacerbations and/or acute lower respiratory tract infections requiring antibiotics. Started Aug 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
asthmanon-eosinophilic asthma (NEA)
Beyond the preview
Go deeper on 2008-004089-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004089-15.